Page URL:

Women with BRCA mutation 'should have ovaries removed by age 35'

3 March 2014
Appeared in BioNews 744

Ovary removal to prevent cancer in those with mutations in the BRCA1 gene should be carried out by 35, according to research on cancer survival.

In a study on 5,783 women with BRCA mutations, women who had ovary removal surgery after 35 were five times more likely to develop ovarian cancer than those who had surgery before 35. They also had a four times higher risk of premature death.

'For women with BRCA1 mutations, these results suggest that surgery should be performed as soon as it is practical', said Dr Don Dizon from the American Society of Clinical Oncology, the organisation whose journal published the study.

The study authors estimate that a BRCA1 carrier who has their ovaries removed after age 40 will have a four percent chance of being diagnosed with cancer. If removal happens after age 50, this rises to 14 percent.

However, BRCA1 carriers who waited until age 40 for ovary removal had a 1.5 percent chance of developing ovarian cancer, which is comparable to the lifetime risk of ovarian cancer in women without a BRCA mutation of 1.4 percent.

In all BRCA mutation carriers, ovary removal reduced the risk of ovarian, fallopian tube or peritoneal cancer by 80 percent and the risk of premature death from any cause by 77 percent.

The study did not show the same effect of earlier ovary removal on BRCA2 mutation carriers. Although they had a decreased risk of cancer after ovary removal, there was no clear increased cancer risk for BCRA2 carriers who delayed ovary removal until after age 40.

Mutations in the genes BRCA1 or 2 increase the risk of breast and ovarian cancers. Surgical removal of breasts (mastectomy) and ovaries (oophorectomy) has long been recommended for BRCA mutation carriers to prevent onset of cancer of these tissues. Removing the ovaries is major surgery, triggers menopause and prevents egg production and pregnancy, so delaying the procedure does have quality-of-life benefits.

Dr Steven Narod of the University of Toronto, who led the study, said, 'These data are so striking that we believe prophylactic oophorectomy by age 35 should become a universal standard for women with BRCA1 mutations'.

'We've always known that the earlier oophorectomy is performed, the greater the protection against both breast and ovarian cancer,' said Dr Noah Kauff, director of ovarian cancer screening and prevention at Memorial Sloan Kettering Cancer Center. 'But you don't fall off a cliff at age 35 or even 40'.

Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
Journal of Clinical Oncology |  24 February 2014
In women with BRCA mutation, early ovary removal may save lives- Canadian study
Reuters |  24 February 2014
Preventive oophorectomy reduces risk of death by 77 percent for women with BRCA mutation
Eurekalert (press release) |  24 February 2104
Study: Women with BRCA1 mutations should remove ovaries by 35
CNN |  25 February 2014
10 August 2015 - by Dr Barbara Kramarz 
In this Radio 4 programme, Dr Aarathi Prasad investigates new research that is overturning decades-old assumptions about how human eggs are produced and what causes the menopause...
15 June 2015 - by Dr Julia Hill 
A woman who has received a transplant of ovarian tissue stored when she was a child has given birth. It is believed to be the first time ovarian tissue taken from young girl has led to a successful pregnancy...
28 April 2014 - by James Brooks 
Did Angelina Jolie's famous editorial in the New York Times a year ago inspire an overemphasis on genetic risk in breast cancer? Or has it saved lives by bringing the issue out into the open?...
7 April 2014 - by Baroness Delyth Morgan 
The news of Angelina Jolie's mastectomy last year brought breast cancer genetics, risk and prevention into the international spotlight. Her decision was only possible due to the efforts of researchers, over the past twenty years and more, to identify the inherited genetic mutations...
31 March 2014 - by Dr Sarah Spain 
BRCA1 mutations put carriers at high risk of cancer by failing to protect cells against the effects of high levels of oestrogen hormone found in breast and ovary tissue, researchers have established...
2 December 2013 - by Dr Charlotte Warren-Gash 
Women from families with a history of carrying the cancer risk gene BRCA2, but who test negative for it, may be at higher risk of breast cancer than previously thought...
28 May 2013 - by James Brooks 
A British man has had his prostate removed after testing positive for a mutation in the BRCA2 gene known to greatly increase the risk of cancer. The operation is thought to be the first prostatectomy performed due to an assessment of genetic risk...
11 March 2013 - by Dr Daniel Grimes 
The source of stem cell-like cells that can give rise to ovarian cancer in mice has been found, reports a study in the journal Nature...
15 August 2011 - by Dr Maria Teresa Esposito 
Scientists have discovered a rare genetic fault that raises a woman's risk of developing ovarian cancer six-fold. It has been hailed as the most important discovery in the field in the last ten years, and offers hope for new treatments...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.